The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Newly Updated HIV Treatment Guidelines For Adults And Adolescents Available On The World Wide Web

An updated version of the Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents has been posted to the AIDS Treatment Information Service (ATIS) Web site, www.hivatis.org.

The Guidelines were developed by the Panel on Clinical Practices for the Treatment of HIV Infection, a joint effort of the Department of Health and Human Services and the Henry J. Kaiser Family Foundation. The Guidelines were constructed as a "living document" and are updated frequently by the Panel.

"We feel that the Guidelines are an invaluable resource to all health care providers who care for HIV-infected individuals," says Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID) and co-chair of the Panel. The Guidelines were published in hard-copy form in the Morbidity and Mortality Weekly Report and in the Annals of Internal Medicine in 1998; however, they are updated frequently on the ATIS Web site. In addition, a hard copy of the most recent version of the Guidelines can be obtained for free by calling 1-800-448-0440.

Included in the latest version of the Guidelines are recommendations for the use of the recently approved anti-HIV drug abacavir (trade name Ziagen). Abacavir is a potent anti-HIV agent belonging to a class of drugs known as nucleoside analog reverse transcriptase inhibitors. This family of drugs also includes zidovudine (AZT) and lamivudine (3TC).

Clinical trials of abacavir combined with AZT and 3TC have shown that this combination suppresses HIV replication and boosts CD4+ T-cell counts to a degree comparable to widely used treatment regimens that combine a protease inhibitor drug with AZT and 3TC. CD4+ T cells are the crucial immune system cells depleted during the course of HIV disease.

The Panel notes that the potential advantages of the abacavir+AZT+3TC regimen include ease of administration (two pills twice daily), and
'"/>

Contact: Greg Folkers
gfolkers@nih.gov
301-496-2263
NIH/National Institute of Allergy and Infectious Diseases
5-May-1999


Page: 1 2 3

Related medicine news :

1. Newly discovered pathway might help in design of cancer drugs
2. Newly identified gene cluster on mouse X chromosome provides insights into fertility
3. Newly discovered virus linked to childhood lung disorders and Kawasaki disease
4. Newly-described route to cancer solves a mystery in lung cancer
5. Newly approved psoriasis drug invented and tested at Univ. of Michigan
6. Newly published data show at-home dialysis therapy may benefit more patients
7. Newly revised recommendations affirm medicine
8. Osteoporosis Drug Evista (Raloxifene) Cuts Newly Diagnosed, Invasive Breast Cancer Risk By More Than 60 Percent
9. For Patients With Advanced Prostate Cancer, Newly Evaluated Drug May Offer Pain Relief And Mild Delay In Disease Progression
10. Updated adjuvant data presented at SABCS show 30 percent reduction in recurrence
11. Updated press release to October 2004 Cochrane Review

Post Your Comments:
(Date:11/23/2009)..., NEW YORK (Nov. 23, 2009) -- A first-of-its-kind...hed online today in the Annals of Surgery . The r...ational consensus conference -- Diabetes Surgery S...e than 50 scientific and medical experts agreed on...s that are meant to guide the use and study of gas...
(Date:11/23/2009)... More than three-quarters getting chemo deal with ...3 (HealthDay News) -- Insomnia and sleep disorders...s undergoing chemotherapy, a rate nearly three tim...ew study finds. , The problem is more common in...t cancers, said University of Rochester Medical Ce...
(Date:11/23/2009)... Dr. Bernadine Healy, first woman to head the agen...AY, Nov. 23 (HealthDay News) -- The fallout from l... delay the start of routine mammogram testing for ... U.S. National Institutes of Health advising women...owerfully ignore them, because unequivocally this ...
(Date:11/23/2009)...,, PartnershipswithMinorityBanksin Washing...olumbia , S.C. IntendedtoSpurEconomicGrowthandR...ire-USNewswire/--DaVita,thenation,sleadingprovider...dmembersoftheAnacostiacommunityfora$1millioninvest...estinginminoritycommunities. ,, DaVita,sinvestm...
(Date:11/23/2009)...,, PartnershipswithMinorityBanksin Washing... Calif. and Columbia , S.C. IntendedtoSpurEc...v.23/PRNewswire-USNewswire/--DaVita,thenation,slea...onwideMinorityBankInitiativedesignedtocreatejobsan...ountrywithinvestmentsinleadingcommunityandminority...
Breaking Medicine News(10 mins):Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 2Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 4Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 5Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 2Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 2Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 4Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 2Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 3
(Date:11/23/2009)...ingtheFDAapprovalsoftwonewtherapiesforNon-Hodgkin,...atedtoincludeofatumumab(Azerra(TM),GlaxoSmithKline...leukemia(CLL)andromidepsin(Istodax(R),GloucesterPh...cutaneousT-celllymphoma(CTCL). ,, FORTWASHINGTO...pprovalshavepromptedtheNationalComprehensiveCancer...
(Date:11/23/2009)...K,Nov.23/PRNewswire/--Reportlinker.comannouncestha.... ,, AnesthesiaDisposables-AWorldMarketReview ...thesia-Disposables---A-World-Market-Review.html#ut...aign=prnewswire ,, Globalgeneralanesthesiad...ration.Despitetheconsiderablerisewitnessedingenera...
(Date:11/23/2009)...DLANDS,Texas,Nov.23/PRNewswire-FirstCall/-- Lexico...aythattop-linedatafromitsPhase2clinicalstudywith L...syndrome(IBS)willbepresentedatGASTRO2009inLondonth...improvementinIBSsymptoms,willbepresentedbyDr. Phil...evelopment,onNovember25,2009at2:30pmlocaltimeatthe...
Breaking Medicine Technology:NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 3Reportlinker Adds Anesthesia Disposables - A World Market Review 2Reportlinker Adds Anesthesia Disposables - A World Market Review 3Reportlinker Adds Anesthesia Disposables - A World Market Review 4Reportlinker Adds Anesthesia Disposables - A World Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 6Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Galil Medical Announces Establishment of Global Headquarters in Minneapolis MN 5093 1Galil Medical Announces Establishment of Global Headquarters in Minneapolis MN 5093 2Michael J Fox Foundation Funded Team Pursuing Glutamate Based Treatment for Parkinsons Disease Hits Major Milestone 5090 1Michael J Fox Foundation Funded Team Pursuing Glutamate Based Treatment for Parkinsons Disease Hits Major Milestone 5090 2GenVec Receives National Cancer Institute Grant to Expand Cancer Program 5087 1GenVec Receives National Cancer Institute Grant to Expand Cancer Program 5087 2
Other News:
Peter Agre, M.D., 54, professor of biological chemistry at the Johns Hopkins University School of Medicine, today was awarded the 2003 Nobel Prize in Chemistry by the Royal Swedish Academy of Sciences
...The American College of Gastroenterology (ACG) is ...al (GI) professionals committed to the...scientifi...gastrointestinal...(GI) tract.......WHAT: ...Ir...mmon GI disorders in the United States, affectng o...
...TE, Ind. - The way a doctor explains clinical tria...n whether to participate, says a Purdue University...conversation analyst, studied how physicians commu...breast cancer clinical trials, which are studies t...
...tone Institute of Virology and Immunology (GIVI) C...mmunology of HIV Infection will take place October...d leaders in HIV immunology......."Understanding h...m on which HIV vaccine research relies," said Warn...
health news:Hopkins' Peter Agre receives 2003 Nobel Prize in chemistry 2health news:Hopkins' Peter Agre receives 2003 Nobel Prize in chemistry 3health news:Hopkins' Peter Agre receives 2003 Nobel Prize in chemistry 4health news:Study: Doctor's communication style may sway cancer patients 2health news:HIVs assault on immune system explored at UCSF/Gladstone center for AIDS research symposium 2
...h rats have found the first solid evidence that st... differently than younger brains. ......This disco...sue of Nature Neuroscience released online Nov. 13..., it could lead eventually to the development of n...
...tors or other non-steroidal anti-inflammatory drug...h doses, increases the risk of death, researchers ...tific Sessions 2005.......Researchers note that th...ubt about the beneficial effects of aspirin among ...
...n the latest advances in medical technologies, dru...rchers do not communicate, according to a British ...he keynote address at a health conference in Canbe...r of Health Care Policy and Management at the Univ...
...ssed ethical issues at the individual level, parti... The ethical issues arising in regard to health at... involve higher stakes. This conference maps a new...tion.......Dates:...Thursday, November 17, 2005 - ...
health news:'Sharp' older brains are not the same as younger brains 2health news:Most NSAIDs raise risk of death after heart attack 2health news:Most NSAIDs raise risk of death after heart attack 3health news:Fourth Health Services and Research Policy Conference 2health news:Population-level bioethics: Mapping a new agenda 2health news:Population-level bioethics: Mapping a new agenda 3